glp 1 drugs and cholesterol Comparing Ozempic, Wegovy Other GLP-1 How GLP-1 medications are transforming
Description
Back Kosaka, T, Lim, RSK (June 1930) 'Demonstration of the humoral agent in fat inhibition of gastric secretion', Journal of Experimental Biology and Medicine , 27/9, 890-91
Amgen is exploring novel biologics and peptide-based therapies, including GLP-1 receptor agonists, aiming to expand treatment options for obesity and diabetes
Author Contributions All authors contributed to the conception and design of the study
Sources [1]Abodi, Agostoni, Mazzocchi (2026): GLP-1 receptor agonists in pediatric obesity (Digestive and Liver Disease
Evaluating the fat distribution in idiopathic intracranial hypertension using dual-energy x-ray absorptiometry scanning
